Pierce G E, Watts L M
Department of Surgery, University of Kansas Medical Center, Kansas City 66160.
Transplantation. 1993 Apr;55(4):882-7. doi: 10.1097/00007890-199304000-00037.
Mixed lymphoid chimeras can be established across H-2b-->H-2d by injection of C57BL/6J (B-6) donor bone marrow cells into BALB/c hosts conditioned by sublethal irradiation, 235 cGy x3. These chimeras are specifically tolerant to both donor and host alloantigens. Tolerance cannot be broken even by injection of 4 x 10(8) normal BALB/c spleen cells (SC), suggesting a suppressor mechanism. In contrast to conventional suppression, however, in which suppressors are syngeneic to the cells they suppress, tolerance can be transferred only by cells of the allogeneic donor allotype (1,2). Thy 1+ cell depletion eliminates the capacity of the donor population to transfer tolerance and markedly reduces the capacity of B-6 BMC to induce tolerance (3). In the present studies spleen cells from tolerant chimeras (CSC), when coinjected in a 1:1 ratio, reduced the high GVHD mortality induced in irradiated H-2d/b F1 hybrids by injection of 2 x 10(7) normal BALB/c SC alone (P < .01). When coinjected at a 5:1 ratio CSC eliminated the GVHD mortality and weight loss induced by 5 x 10(6) BALB/c SC (P < .01). Depletion of B-6 cells from CSC removed their capacity to inhibit the GVHD induced by normal BALB/c SC. In contrast to conventional suppression, which requires the continued presence of suppressor cells, the BALB/c cells isolated from CSC, although unable to inhibit the GVHD of normal BALB/c SC, remained nonreactive against the H-2b allotype for a prolonged period following depletion of the B-6 cells. This prolonged response reduction dependent upon some interaction with allogeneic donor cells--which, in turn, are specifically nonreactive to host antigens--is compatible with a veto mechanism.
通过将C57BL/6J(B-6)供体骨髓细胞注射到经235 cGy×3次亚致死剂量照射预处理的BALB/c宿主中,可建立跨越H-2b至H-2d的混合淋巴细胞嵌合体。这些嵌合体对供体和宿主同种异体抗原均具有特异性耐受性。即使注射4×10⁸个正常BALB/c脾细胞(SC),耐受性也无法被打破,提示存在一种抑制机制。然而,与传统抑制不同,传统抑制中抑制细胞与其所抑制的细胞是同基因的,而这种耐受性只能由同种异体供体同种异型的细胞转移(1,2)。去除Thy 1⁺细胞可消除供体细胞群体转移耐受性的能力,并显著降低B-6骨髓细胞诱导耐受性的能力(3)。在本研究中,将耐受性嵌合体的脾细胞(CSC)以1:1的比例共同注射时,可降低单独注射2×10⁷个正常BALB/c SC所诱导的经照射的H-2d/b F1杂种小鼠的高移植物抗宿主病(GVHD)死亡率(P <.01)。当以5:1的比例共同注射时,CSC可消除由5×10⁶个BALB/c SC诱导的GVHD死亡率和体重减轻(P <.01)。从CSC中去除B-6细胞可消除其抑制正常BALB/c SC诱导的GVHD的能力。与传统抑制不同,传统抑制需要抑制细胞持续存在,从CSC中分离出的BALB/c细胞,尽管无法抑制正常BALB/c SC的GVHD,但在去除B-6细胞后,对H-2b同种异型在较长时间内仍无反应。这种依赖于与同种异体供体细胞某种相互作用的延长的反应降低——而同种异体供体细胞又对宿主抗原具有特异性无反应——与否决机制相符。